$28.94
2.89% yesterday
Nasdaq, Jun 11, 10:00 pm CET
ISIN
US79957L1008
Symbol
SMTI

Sanara MedTech Inc Stock price

$28.94
-5.43 15.80% 1M
-6.97 19.41% 6M
-4.26 12.83% YTD
-2.05 6.62% 1Y
+12.94 80.88% 5Y
+18.94 189.40% 10Y
-6.06 17.31% 20Y
Nasdaq, Closing price Wed, Jun 11 2025
-0.86 2.89%
ISIN
US79957L1008
Symbol
SMTI
Sector

Key metrics

Market capitalization $257.21m
Enterprise Value $279.92m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.06
P/S ratio (TTM) P/S ratio 2.81
P/B ratio (TTM) P/B ratio 7.03
Revenue growth (TTM) Revenue growth 34.66%
Revenue (TTM) Revenue $91.57m
EBIT (operating result TTM) EBIT $-7.26m
Free Cash Flow (TTM) Free Cash Flow $-2.31m
Cash position $20.69m
EPS (TTM) EPS $-1.34
P/E forward negative
P/S forward 2.47
EV/Sales forward 2.69
Short interest 4.38%
Show more

Is Sanara MedTech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,840 stocks worldwide.

Sanara MedTech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Sanara MedTech Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Sanara MedTech Inc forecast:

Buy
100%

Financial data from Sanara MedTech Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
92 92
35% 35%
100%
- Direct Costs 8.08 8.08
6% 6%
9%
83 83
38% 38%
91%
- Selling and Administrative Expenses 79 79
32% 32%
87%
- Research and Development Expense 5.87 5.87
56% 56%
6%
-2.83 -2.83
424% 424%
-3%
- Depreciation and Amortization 4.44 4.44
11% 11%
5%
EBIT (Operating Income) EBIT -7.26 -7.26
60% 60%
-8%
Net Profit -11 -11
134% 134%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about Sanara MedTech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanara MedTech Inc Stock News

Neutral
Seeking Alpha
3 days ago
Sanara MedTech's surgical revenue grew 26% year-over-year in Q1, with a gross margin of 92%. Surgical adjusted EBITDA was $2.7 million in Q1, while THP correspondingly posted a loss of $2 million. High debt levels and elevated interest expenses are key risks, along with the uncertainty surrounding the commercialization of THP.
Neutral
Seeking Alpha
29 days ago
Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman, Chief Executive Officer Seth Yon - President, Chief Commercial Officer Sam Muppalla - President, Chief Executive Officer of Tissue Health Plus Elizabeth Taylor - Chief Financial Officer Conference Call Participants Matt Park - Cantor Fitzgerald Operato...
Neutral
GlobeNewsWire
29 days ago
Q1 Net Revenue Increased 26% Year-Over-Year FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today...
More Sanara MedTech Inc News

Company Profile

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Head office United States
CEO Ron Nixon
Employees 108
Founded 1982
Website sanaramedtech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today